syndrome	score	normalized_score
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	2.00408163	100.0
DIBASIC AMINO ACIDURIA I	1.642857	81.97555306167843
NEUROBLASTOMA, SUSCEPTIBILITY TO	1.5	74.84725060824992
SACCHAROPINURIA	1.47619	73.65917525026163
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	1.47619	73.65917525026163
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	1.4289680999999999	71.30288899459649
#557000 PEARSON MARROW-PANCREAS SYNDROME;;SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATICDYSFUNCTION	1.25854701	62.79918897315575
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	1.111111	55.44240231372212
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	1.1037449099999999	55.074847924233495
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	1.1020202000000001	54.98878805650248
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	1.025	51.14562124897078
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	1.025	51.14562124897078
DICARBOXYLICAMINO ACIDURIA	1.0217391	50.98290831596516
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	1.01965811	50.87907072926965
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	1.00854701	50.32464720511409
DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	1.00490196	50.14276589122769
HARTNUP DISORDER	1.0	49.898167072166615
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	1.0	49.898167072166615
#276880 UROCANASE DEFICIENCY	1.0	49.898167072166615
PENTOSURIA	1.0	49.898167072166615
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.833333	41.58178926074982
HAWKINSINURIA	0.833333	41.58178926074982
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.833333	41.58178926074982
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.75	37.42362530412496
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.667857	33.32484016631598
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.642857	32.07738598951181
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.6217391	31.02364148709851
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.6150791	30.69131969439788
MEVALONIC ACIDURIA; MEVA	0.51939476	25.91684651088788
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.5158726	25.74109718275298
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.5158726	25.74109718275298
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.5111111	25.50350706023886
KETOADIPICACIDURIA	0.5	24.949083536083307
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.5	24.949083536083307
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.5	24.949083536083307
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.5	24.949083536083307
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.5	24.949083536083307
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.5	24.949083536083307
HYPERTRYPTOPHANEMIA; HYPTRP	0.5	24.949083536083307
THREONINEMIA	0.5	24.949083536083307
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.5	24.949083536083307
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5	24.949083536083307
TRYPTOPHANURIA WITH DWARFISM	0.5	24.949083536083307
LEBER CONGENITAL AMAUROSIS, TYPE I	0.5	24.949083536083307
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	24.949083536083307
HYPERPROLINEMIA, TYPE I	0.4837661	24.13904168165046
IMINOGLYCINURIA	0.4837661	24.13904168165046
HYPERPROLINEMIA, TYPE II	0.4837661	24.13904168165046
DIAMINOPENTANURIA	0.47619	23.76100817809502
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.392857	19.60284422147016
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.35	17.464358475258315
TYROSINE TRANSAMINASE DEFICIENCY	0.3459912	17.264326703099414
HYPOTONIA-CYSTINURIA SYNDROME	0.34188001	17.059185857613997
MUSCULAR DYSTROPHY, CARDIAC TYPE	0.33823496	16.877304543727593
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.33741463	16.83637158033328
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.33741463	16.83637158033328
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.3333333	16.63272069411664
HISTIDINEMIA	0.333333	16.632705724666515
CARNOSINEMIA	0.333333	16.632705724666515
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1	0.333333	16.632705724666515
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.333333	16.632705724666515
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.333333	16.632705724666515
CYSTATHIONINURIA	0.333333	16.632705724666515
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	16.632705724666515
HOMOCARNOSINOSIS	0.333333	16.632705724666515
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.28455980000000003	14.19901244242232
METHYLMALONIC ACIDURIA, CBLA TYPE	0.2789682	13.92000185142159
METHYLMALONIC ACIDURIA, CBLB TYPE	0.2789682	13.92000185142159
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.25854701	12.901021900989134
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.25	12.474541768041654
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.25	12.474541768041654
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.25	12.474541768041654
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.25	12.474541768041654
OCULOECTODERMAL SYNDROME; OES	0.25	12.474541768041654
LYMPHEDEMA, HEREDITARY, III	0.25	12.474541768041654
FRYNS SYNDROME; FRNS	0.25	12.474541768041654
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.25	12.474541768041654
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.25	12.474541768041654
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.24101306	12.026109934454118
TIGLIC ACIDEMIA	0.2328501	11.618793192570704
GLUTARIC ACIDEMIA I; GA1	0.2253967	11.246882194115019
HYPEROXALURIA, PRIMARY, TYPE II; HP2	0.22173910000000002	11.064374658231863
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.21965811000000002	10.960537071536354
RIBOFLAVIN DEFICIENCY	0.21111110000000002	10.534056938588874
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.211111	10.534051948772166
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.20490196000000002	10.224232233494403
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.2	9.979633414433325
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.2	9.979633414433325
NEPHROLITHIASIS, CALCIUM OXALATE	0.2	9.979633414433325
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.2	9.979633414433325
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.2	9.979633414433325
#613616 HYPEROXALURIA, PRIMARY, TYPE III; HP3	0.2	9.979633414433325
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.2	9.979633414433325
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.2	9.979633414433325
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.2	9.979633414433325
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.2	9.979633414433325
BARTH SYNDROME; BTHS	0.19444430000000001	9.702414167630488
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.1825396	9.108391458086466
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.1825396	9.108391458086466
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.1825396	9.108391458086466
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.166667	8.316377811416794
HYPER-BETA-ALANINEMIA	0.166667	8.316377811416794
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.166667	8.316377811416794
CAMPTODACTYLY 1; CAMPD1	0.166667	8.316377811416794
HYPERTAURINURIC CARDIOMYOPATHY	0.166667	8.316377811416794
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.166667	8.316377811416794
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.14285720000000002	7.128312433061922
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.14285699999999998	7.128302453428506
HYDROXYLYSINURIA	0.14285699999999998	7.128302453428506
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.14285699999999998	7.128302453428506
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.14285699999999998	7.128302453428506
BRUCK SYNDROME 2	0.14285699999999998	7.128302453428506
FAMILIAL EXPANSILE OSTEOLYSIS	0.14285699999999998	7.128302453428506
LYSINE MALABSORPTION SYNDROME	0.14285699999999998	7.128302453428506
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.13728851	6.850445009068817
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.13611099999999998	6.79168941835967
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.13611099999999998	6.79168941835967
PROPIONIC ACIDEMIA	0.13556721	6.764555294087497
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.13289337	6.631135579043256
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.1328501	6.628976485354042
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.13076911	6.5251388986585335
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.13076911	6.5251388986585335
MAPLE SYRUP URINE DISEASE; MSUD	0.13076911	6.5251388986585335
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.13076911	6.5251388986585335
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.12799141	6.386536759982177
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.12222209999999999	6.098658765711055
GLYCOGEN STORAGE DISEASE IXA	0.12222209999999999	6.098658765711055
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.12222209999999999	6.098658765711055
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.1217391	6.0745579510151995
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.1217391	6.0745579510151995
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.12098867	6.037112869499233
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.11965800999999998	5.970715374502983
GLYCOGEN STORAGE DISEASE IXC	0.11965800999999998	5.970715374502983
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.11688031000000002	5.832113235826627
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.11608671000000001	5.792514050438156
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.11601295999999998	5.7888340606165825
GLYCOGEN STORAGE DISEASE 0, LIVER	0.11111099999999999	5.544235241555504
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.11111099999999999	5.544235241555504
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.11111099999999999	5.544235241555504
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.11111099999999999	5.544235241555504
Cerebral creatine deficiency syndrome 3	0.11111099999999999	5.544235241555504
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.11111099999999999	5.544235241555504
CYSTINOSIS, NEPHROPATHIC; CTNS	0.11111099999999999	5.544235241555504
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.11111099999999999	5.544235241555504
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.11111099999999999	5.544235241555504
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.11111099999999999	5.544235241555504
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.10661667000000001	5.319976412338055
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.10171471000000001	5.075377593276977
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.1	4.989816707216662
NOONAN SYNDROME 8; NS8	0.1	4.989816707216662
HEMOCHROMATOSIS, TYPE 1	0.1	4.989816707216662
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.1	4.989816707216662
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.1	4.989816707216662
PANCREATITIS, HEREDITARY	0.1	4.989816707216662
VICI SYNDROME; VICIS	0.1	4.989816707216662
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.1	4.989816707216662
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.1	4.989816707216662
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.1	4.989816707216662
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.1	4.989816707216662
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.1	4.989816707216662
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.1	4.989816707216662
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0964286	4.811610393335126
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.09188031000000002	4.584659059022463
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.09108671000000002	4.545059873633991
GLUCOGLYCINURIA	0.0909091	4.536197460180302
GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS	0.0909091	4.536197460180302
GLYCINE ENCEPHALOPATHY; GCE	0.0909091	4.536197460180302
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.0909091	4.536197460180302
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.0909091	4.536197460180302
HYDROXYKYNURENINURIA	0.0842391	4.2033766858089505
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.08333330000000001	4.158178926074983
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.08333330000000001	4.158178926074983
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.08333330000000001	4.158178926074983
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.08333330000000001	4.158178926074983
SENGERS SYNDROME	0.08333330000000001	4.158178926074983
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.08253970000000001	4.118579740686512
ALKAPTONURIA	0.07551023000000001	3.767822072197728
FASCIAL DYSTROPHY, CONGENITAL	0.07515820000000001	3.7502564204433133
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.07142860000000001	3.564156216530961
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.07142860000000001	3.564156216530961
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.07142860000000001	3.564156216530961
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.07142860000000001	3.564156216530961
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.07142860000000001	3.564156216530961
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.07142860000000001	3.564156216530961
RICHARDS-RUNDLE SYNDROME; RRNS	0.07142860000000001	3.564156216530961
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.07142860000000001	3.564156216530961
#613646 METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT;;METHYLMALONIC ACIDEMIA, TCblR TYPE	0.07142860000000001	3.564156216530961
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.07142860000000001	3.564156216530961
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.07142860000000001	3.564156216530961
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.07142860000000001	3.564156216530961
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.07142860000000001	3.564156216530961
KAPUR-TORIELLO SYNDROME	0.07142860000000001	3.564156216530961
MECKEL SYNDROME, TYPE 5	0.07142860000000001	3.564156216530961
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.07142860000000001	3.564156216530961
SMITH-MAGENIS SYNDROME; SMS	0.07142860000000001	3.564156216530961
KOOLEN-DE VRIES SYNDROME; KDVS	0.07142860000000001	3.564156216530961
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.07142860000000001	3.564156216530961
Split hand/foot malformation 1 (SHFM1)	0.07142860000000001	3.564156216530961
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.06658163	3.322301297677181
RHEUMATOID ARTHRITIS	0.0625	3.1186354420104134
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0625	3.1186354420104134
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.0625	3.1186354420104134
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.0625	3.1186354420104134
LICHTENSTEIN SYNDROME	0.0625	3.1186354420104134
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.0625	3.1186354420104134
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.0625	3.1186354420104134
TUBEROUS SCLEROSIS	0.0625	3.1186354420104134
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0625	3.1186354420104134
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.0625	3.1186354420104134
PSEUDOTRISOMY 13 SYNDROME	0.0625	3.1186354420104134
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0625	3.1186354420104134
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.0625	3.1186354420104134
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.056159499999999994	2.802256113689341
VISCERAL STEATOSIS, CONGENITAL	0.05277779999999999	2.6335154821013953
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.0506039	2.5250418567032122
LYSINURIC PROTEIN INTOLERANCE; LPI	0.046739100000000006	2.332195420602703
ARGININOSUCCINIC ACIDURIA	0.046739100000000006	2.332195420602703
GENITOURINARY TRACT ANOMALIES	0.041666699999999994	2.0790919579458444
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.041666699999999994	2.0790919579458444
300270 ADRENOMYODYSTROPHY	0.041666699999999994	2.0790919579458444
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.041666699999999994	2.0790919579458444
PEYRONIE DISEASE	0.041666699999999994	2.0790919579458444
#193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1;;VON WILLEBRAND DISEASE, TYPE I;;VWD, TYPE 1	0.041666699999999994	2.0790919579458444
FRYNS MICROPHTHALMIA SYNDROME	0.041666699999999994	2.0790919579458444
ADENOMYOSIS	0.041666699999999994	2.0790919579458444
207620 APHALANGY WITH HEMIVERTEBRAE	0.041666699999999994	2.0790919579458444
URINARY BLADDER, ATONY OF	0.041666699999999994	2.0790919579458444
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.041666699999999994	2.0790919579458444
NATHALIE SYNDROME	0.041666699999999994	2.0790919579458444
DK PHOCOMELIA SYNDROME	0.041666699999999994	2.0790919579458444
TESTICULAR TORSION	0.041666699999999994	2.0790919579458444
GALACTORRHEA	0.041666699999999994	2.0790919579458444
LABIA MINORA, INCOMPLETE ADHESION OF	0.041666699999999994	2.0790919579458444
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.041666699999999994	2.0790919579458444
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.041666699999999994	2.0790919579458444
OVARIAN HYPERSTIMULATION SYNDROME	0.041666699999999994	2.0790919579458444
HYPERLYSINEMIA, TYPE I	0.041666699999999994	2.0790919579458444
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.041666699999999994	2.0790919579458444
#226730 EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMYLOSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIACUTIS CONGENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA	0.041666699999999994	2.0790919579458444
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.041397210000000004	2.0656449009015665
OTOONYCHOPERONEAL SYNDROME	0.04	1.9959266828866649
NAIL LOW-SULFUR PROTEIN	0.04	1.9959266828866649
NAIL HIGH-SULFUR PROTEIN	0.04	1.9959266828866649
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.04	1.9959266828866649
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.04	1.9959266828866649
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.04	1.9959266828866649
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.04	1.9959266828866649
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.04	1.9959266828866649
ADACTYLIA, UNILATERAL	0.04	1.9959266828866649
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.04	1.9959266828866649
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.04	1.9959266828866649
TOE, ROTATED FIFTH	0.04	1.9959266828866649
CHILBLAIN LUPUS 1	0.04	1.9959266828866649
NAILBEDS, PIGMENTATION OF	0.04	1.9959266828866649
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.04	1.9959266828866649
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.04	1.9959266828866649
JOHANSON-BLIZZARD SYNDROME; JBS	0.04	1.9959266828866649
LUNULAE OF FINGERNAILS	0.04	1.9959266828866649
MOEBIUS SYNDROME; MBS	0.04	1.9959266828866649
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.04	1.9959266828866649
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.04	1.9959266828866649
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.04	1.9959266828866649
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.04	1.9959266828866649
NASODIGITOACOUSTIC SYNDROME	0.04	1.9959266828866649
SCALP-EAR-NIPPLE SYNDROME; SENS	0.04	1.9959266828866649
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.03844897	1.918533128812722
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0361111	1.801877700959716
INFANTILE LIVER FAILURE SYNDROME 2	0.0361111	1.801877700959716
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.0361111	1.801877700959716
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0361111	1.801877700959716
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.03518807	1.755820195807094
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.034901	1.7414959289856873
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.034901	1.7414959289856873
KNIEST-LIKE DYSPLASIA, LETHAL	0.034901	1.7414959289856873
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.034397300000000006	1.7163622222314372
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.03354701	1.6739343097516444
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.03354701	1.6739343097516444
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.03354701	1.6739343097516444
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.0328502	1.6391647679540882
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.0315193	1.5727552973977412
COSTELLO SYNDROME; CSTLO	0.0315193	1.5727552973977412
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.03028611	1.5112213767460163
FUMARASE DEFICIENCY; FMRD	0.03028611	1.5112213767460163
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.03028611	1.5112213767460163
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.03028611	1.5112213767460163
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.03028611	1.5112213767460163
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.03028611	1.5112213767460163
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.02990196	1.4920529958652433
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.02990196	1.4920529958652433
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.02895521	1.4448119061896696
#300555 DENT DISEASE 2	0.02664106	1.3293400628596153
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0256039	1.2775876798990469
SPLENOPORTAL VASCULAR ANOMALIES	0.025	1.2474541768041656
PATENT DUCTUS VENOSUS	0.025	1.2474541768041656
GLUTAMINE DEFICIENCY, CONGENITAL	0.025	1.2474541768041656
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.025	1.2474541768041656
CITRULLINEMIA, CLASSIC	0.025	1.2474541768041656
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.025	1.2474541768041656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.025	1.2474541768041656
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.025	1.2474541768041656
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.025	1.2474541768041656
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.025	1.2474541768041656
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.024489829999999997	1.221997628908958
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.024489829999999997	1.221997628908958
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.02303981	1.1496442886909752
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.02303981	1.1496442886909752
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.0217391	1.0847412437985375
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.0217391	1.0847412437985375
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0217391	1.0847412437985375
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.0217391	1.0847412437985375
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.0217391	1.0847412437985375
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0217391	1.0847412437985375
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0217391	1.0847412437985375
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0217391	1.0847412437985375
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0217391	1.0847412437985375
GALACTOSE EPIMERASE DEFICIENCY	0.0217391	1.0847412437985375
ROWLEY-ROSENBERG SYNDROME	0.0217391	1.0847412437985375
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0217391	1.0847412437985375
BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF	0.0217391	1.0847412437985375
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.0217391	1.0847412437985375
GALACTOSEMIA	0.0217391	1.0847412437985375
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.0217391	1.0847412437985375
LOWE OCULOCEREBRORENAL SYNDROME	0.0217391	1.0847412437985375
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.0217391	1.0847412437985375
WILSON DISEASE	0.0217391	1.0847412437985375
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0217391	1.0847412437985375
DENT DISEASE 1	0.0217391	1.0847412437985375
FORMIMINOTRANSFERASE DEFICIENCY	0.0217391	1.0847412437985375
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0217391	1.0847412437985375
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	1.0183317732421906
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	1.0183317732421906
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.020408199999999998	1.0183317732421906
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	1.0183317732421906
ROIFMAN SYNDROME; RFMN	0.020408199999999998	1.0183317732421906
NEMALINE MYOPATHY 10	0.020408199999999998	1.0183317732421906
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.0183317732421906
GAUCHER DISEASE, PERINATAL LETHAL	0.020408199999999998	1.0183317732421906
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.020408199999999998	1.0183317732421906
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.0183317732421906
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	1.0183317732421906
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.020408199999999998	1.0183317732421906
YUNIS-VARON SYNDROME	0.020408199999999998	1.0183317732421906
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.0183317732421906
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.020408199999999998	1.0183317732421906
INFANTILE SIALIC ACID STORAGE DISEASE	0.020408199999999998	1.0183317732421906
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	1.0183317732421906
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.0183317732421906
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.020408199999999998	1.0183317732421906
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	1.0183317732421906
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.0183317732421906
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020408199999999998	1.0183317732421906
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.020408199999999998	1.0183317732421906
TEMPLE SYNDROME	0.020408199999999998	1.0183317732421906
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.0183317732421906
TYSHCHENKO SYNDROME	0.020408199999999998	1.0183317732421906
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.020408199999999998	1.0183317732421906
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.020408199999999998	1.0183317732421906
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.020408199999999998	1.0183317732421906
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.0183317732421906
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.020408199999999998	1.0183317732421906
Diamond-Blackfan anemia 1	0.020408199999999998	1.0183317732421906
KAGAMI-OGATA SYNDROME	0.020408199999999998	1.0183317732421906
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	1.0183317732421906
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	1.0183317732421906
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.0183317732421906
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.0183317732421906
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	1.0183317732421906
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.020408199999999998	1.0183317732421906
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.020408199999999998	1.0183317732421906
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.01965811	0.9809036571030293
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.01965811	0.9809036571030293
NAVAJO NEUROHEPATOPATHY	0.01965811	0.9809036571030293
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.01965811	0.9809036571030293
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.01965811	0.9809036571030293
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.01965811	0.9809036571030293
PYRUVATE CARBOXYLASE DEFICIENCY	0.01965811	0.9809036571030293
GLYCOGEN STORAGE DISEASE IB	0.01965811	0.9809036571030293
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.01965811	0.9809036571030293
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.01965811	0.9809036571030293
GLYCOGEN STORAGE DISEASE IA	0.01965811	0.9809036571030293
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.01965811	0.9809036571030293
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.01965811	0.9809036571030293
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.01965811	0.9809036571030293
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01965811	0.9809036571030293
KERATOSIS, FAMILIAL ACTINIC	0.01673983	0.835286834099667
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.01673983	0.835286834099667
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.01673983	0.835286834099667
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.01673983	0.835286834099667
GLOMUVENOUS MALFORMATIONS	0.01673983	0.835286834099667
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.01673983	0.835286834099667
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.016013060000000003	0.7990223432166285
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.016013060000000003	0.7990223432166285
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.016013060000000003	0.7990223432166285
OPSISMODYSPLASIA; OPSMD	0.0144928	0.7231641557434964
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.0144928	0.7231641557434964
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.0144928	0.7231641557434964
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0144928	0.7231641557434964
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.0144928	0.7231641557434964
CLUSTER HEADACHE, FAMILIAL	0.0144928	0.7231641557434964
MASTOCYTOSIS, CUTANEOUS; MASTC	0.0144928	0.7231641557434964
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.0144928	0.7231641557434964
#614196 NEPHROTIC SYNDROME, TYPE 6; NPHS6	0.0144928	0.7231641557434964
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0144928	0.7231641557434964
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0144928	0.7231641557434964
PEHO-LIKE SYNDROME; PEHOL	0.0144928	0.7231641557434964
AMYLOIDOSIS, FAMILIAL VISCERAL	0.0144928	0.7231641557434964
WHITE SPONGE NEVUS 2; WSN2	0.0144928	0.7231641557434964
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.0144928	0.7231641557434964
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.0144928	0.7231641557434964
NOONAN SYNDROME 6; NS6	0.0144928	0.7231641557434964
CHILBLAIN LUPUS 2; CHBL2	0.0144928	0.7231641557434964
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.0144928	0.7231641557434964
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0144928	0.7231641557434964
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0144928	0.7231641557434964
PAPILLORENAL SYNDROME	0.0144928	0.7231641557434964
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.0144928	0.7231641557434964
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0144928	0.7231641557434964
#600972 ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE	0.0144928	0.7231641557434964
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0144928	0.7231641557434964
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.0144928	0.7231641557434964
#253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1;;LCCS;;MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE	0.0144928	0.7231641557434964
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0144928	0.7231641557434964
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.0144928	0.7231641557434964
ENHANCED S-CONE SYNDROME	0.0144928	0.7231641557434964
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.0144928	0.7231641557434964
RETINITIS PIGMENTOSA 71; RP71	0.0144928	0.7231641557434964
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.0144928	0.7231641557434964
RETINAL VENOUS BEADING	0.0144928	0.7231641557434964
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.0144928	0.7231641557434964
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0144928	0.7231641557434964
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.0144928	0.7231641557434964
PREECLAMPSIA/ECLAMPSIA 1	0.0144928	0.7231641557434964
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.0144928	0.7231641557434964
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0144928	0.7231641557434964
%152800 LYMPHANGIECTASIA, INTESTINAL	0.0144928	0.7231641557434964
GLYCOGEN STORAGE DISEASE IV	0.0144928	0.7231641557434964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.0144928	0.7231641557434964
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.0144928	0.7231641557434964
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0144928	0.7231641557434964
#610725 NEPHROTIC SYNDROME, TYPE 3; NPHS3;;NEPHROTIC SYNDROME, EARLY-ONSET, TYPE 3	0.0144928	0.7231641557434964
#600995 NEPHROTIC SYNDROME, TYPE 2; NPHS2;;NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE; SRN1	0.0144928	0.7231641557434964
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	0.0144928	0.7231641557434964
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.0144928	0.7231641557434964
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0144928	0.7231641557434964
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.0144928	0.7231641557434964
#614131 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 6	0.0144928	0.7231641557434964
LIPEDEMA	0.0144928	0.7231641557434964
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0144928	0.7231641557434964
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0144928	0.7231641557434964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0144928	0.7231641557434964
PIERSON SYNDROME	0.0144928	0.7231641557434964
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.0144928	0.7231641557434964
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0144928	0.7231641557434964
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.013448970000000001	0.6710789520085567
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013448970000000001	0.6710789520085567
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.013448970000000001	0.6710789520085567
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.013448970000000001	0.6710789520085567
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.013448970000000001	0.6710789520085567
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.013448970000000001	0.6710789520085567
CALLOSITIES, HEREDITARY PAINFUL	0.012658200000000001	0.6316209784328995
AICARDI SYNDROME; AIC	0.012658200000000001	0.6316209784328995
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.012658200000000001	0.6316209784328995
COMEDONES, FAMILIAL DYSKERATOTIC	0.012658200000000001	0.6316209784328995
SPINOCEREBELLAR ATAXIA 34; SCA34	0.012658200000000001	0.6316209784328995
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.012658200000000001	0.6316209784328995
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.012658200000000001	0.6316209784328995
CURRY-JONES SYNDROME	0.012658200000000001	0.6316209784328995
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.012658200000000001	0.6316209784328995
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.012658200000000001	0.6316209784328995
PERIODONTITIS, AGGRESSIVE, 1	0.012658200000000001	0.6316209784328995
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.012658200000000001	0.6316209784328995
PSEUDOATROPHODERMA COLLI	0.012658200000000001	0.6316209784328995
TRICHILEMMAL CYST 1	0.012658200000000001	0.6316209784328995
131600 EPIDERMOID CYSTS	0.012658200000000001	0.6316209784328995
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.012658200000000001	0.6316209784328995
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.012658200000000001	0.6316209784328995
ACROMIAL DIMPLES	0.012658200000000001	0.6316209784328995
SIMOSA CRANIOFACIAL SYNDROME	0.012658200000000001	0.6316209784328995
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.012658200000000001	0.6316209784328995
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.012658200000000001	0.6316209784328995
SYRINGOMAS, MULTIPLE	0.012658200000000001	0.6316209784328995
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.012658200000000001	0.6316209784328995
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.012658200000000001	0.6316209784328995
LENTIGINES	0.012658200000000001	0.6316209784328995
SAY SYNDROME	0.012658200000000001	0.6316209784328995
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.012658200000000001	0.6316209784328995
CAROTENEMIA, FAMILIAL	0.012658200000000001	0.6316209784328995
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.012658200000000001	0.6316209784328995
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.012658200000000001	0.6316209784328995
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.012658200000000001	0.6316209784328995
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.012658200000000001	0.6316209784328995
MUCOPOLYSACCHARIDOSIS TYPE IX	0.012658200000000001	0.6316209784328995
SHORT SYNDROME	0.012658200000000001	0.6316209784328995
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.012658200000000001	0.6316209784328995
MARFANOID HYPERMOBILITY SYNDROME	0.012658200000000001	0.6316209784328995
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.012658200000000001	0.6316209784328995
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.012658200000000001	0.6316209784328995
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.012658200000000001	0.6316209784328995
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.012658200000000001	0.6316209784328995
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.012658200000000001	0.6316209784328995
FUTCHER LINE	0.012658200000000001	0.6316209784328995
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.012658200000000001	0.6316209784328995
LATERAL MENINGOCELE SYNDROME	0.012658200000000001	0.6316209784328995
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.012658200000000001	0.6316209784328995
PRENATAL BOWING	0.012658200000000001	0.6316209784328995
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.012658200000000001	0.6316209784328995
DERMAL RIDGES, PATTERNLESS	0.012658200000000001	0.6316209784328995
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.012658200000000001	0.6316209784328995
#300299 NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX;;XLN	0.012658200000000001	0.6316209784328995
PATELLA APLASIA-HYPOPLASIA	0.012658200000000001	0.6316209784328995
KYRLE DISEASE	0.012658200000000001	0.6316209784328995
PILONIDAL SINUS	0.012658200000000001	0.6316209784328995
DERMATOSIS PAPULOSA NIGRA	0.012658200000000001	0.6316209784328995
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.012658200000000001	0.6316209784328995
LICHEN PLANUS, FAMILIAL	0.012658200000000001	0.6316209784328995
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.012658200000000001	0.6316209784328995
PIGMENTED PURPURIC ERUPTION	0.012658200000000001	0.6316209784328995
#162091 SCHWANNOMATOSIS;;NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS	0.012658200000000001	0.6316209784328995
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.012658200000000001	0.6316209784328995
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.012658200000000001	0.6316209784328995
PARANA HARD-SKIN SYNDROME	0.012658200000000001	0.6316209784328995
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.012658200000000001	0.6316209784328995
INSECT STINGS, HYPERSENSITIVITY TO	0.012658200000000001	0.6316209784328995
CIRCUMVALLATE PLACENTA SYNDROME	0.012658200000000001	0.6316209784328995
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.012658200000000001	0.6316209784328995
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.012658200000000001	0.6316209784328995
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.012658200000000001	0.6316209784328995
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.012658200000000001	0.6316209784328995
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.0111111	0.5544235241555505
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.0111111	0.5544235241555505
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.0111111	0.5544235241555505
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.0111111	0.5544235241555505
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0111111	0.5544235241555505
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0111111	0.5544235241555505
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.0111111	0.5544235241555505
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0111111	0.5544235241555505
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0111111	0.5544235241555505
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0111111	0.5544235241555505
TENORIO SYNDROME; TNORS	0.0111111	0.5544235241555505
MEHMO SYNDROME; MEHMO	0.0111111	0.5544235241555505
SMITH-KINGSMORE SYNDROME; SKS	0.0111111	0.5544235241555505
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0111111	0.5544235241555505
GLYCOGEN STORAGE DISEASE VI	0.0111111	0.5544235241555505
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0111111	0.5544235241555505
Growth hormone deficiency, isolated, type IA	0.0111111	0.5544235241555505
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.0111111	0.5544235241555505
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.0111111	0.5544235241555505
HEMOCHROMATOSIS, NEONATAL	0.0111111	0.5544235241555505
GLYCEROL KINASE DEFICIENCY; GKD	0.0111111	0.5544235241555505
TIMOTHY SYNDROME; TS	0.0111111	0.5544235241555505
TYROSINEMIA, TYPE I; TYRSN1	0.0111111	0.5544235241555505
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0111111	0.5544235241555505
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.0111111	0.5544235241555505
FRUCTOSE AND GALACTOSE INTOLERANCE	0.0111111	0.5544235241555505
HYPOADRENOCORTICISM, FAMILIAL	0.0111111	0.5544235241555505
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.0111111	0.5544235241555505
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.0111111	0.5544235241555505
HOLOPROSENCEPHALY 1; HPE1	0.0111111	0.5544235241555505
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0111111	0.5544235241555505
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.0111111	0.5544235241555505
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.0111111	0.5544235241555505
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0111111	0.5544235241555505
SHASHI-PENA SYNDROME; SHAPNS	0.0111111	0.5544235241555505
MIRAGE SYNDROME; MIRAGE	0.0111111	0.5544235241555505
MYOPATHY, SPHEROID BODY	0.00898359	0.44826467472784526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00854701	0.42648013294747883
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00854701	0.42648013294747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00854701	0.42648013294747883
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00854701	0.42648013294747883
PHENFORMIN 4-HYDROXYLATION	0.00854701	0.42648013294747883
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.00854701	0.42648013294747883
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00854701	0.42648013294747883
KEARNS-SAYRE SYNDROME; KSS	0.00854701	0.42648013294747883
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00854701	0.42648013294747883
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.00854701	0.42648013294747883
INFANTILE LIVER FAILURE SYNDROME 1	0.00854701	0.42648013294747883
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00854701	0.42648013294747883
SUCCINIC ACIDEMIA	0.00854701	0.42648013294747883
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00854701	0.42648013294747883
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00854701	0.42648013294747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00854701	0.42648013294747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00854701	0.42648013294747883
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.00854701	0.42648013294747883
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00854701	0.42648013294747883
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00854701	0.42648013294747883
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.00854701	0.42648013294747883
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00854701	0.42648013294747883
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00854701	0.42648013294747883
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00854701	0.42648013294747883
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00854701	0.42648013294747883
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.00854701	0.42648013294747883
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4	0.00854701	0.42648013294747883
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00854701	0.42648013294747883
#610773 MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY;;MPCD	0.00854701	0.42648013294747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00854701	0.42648013294747883
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00854701	0.42648013294747883
PSEUDO-TORCH SYNDROME 2	0.00854701	0.42648013294747883
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.00854701	0.42648013294747883
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00854701	0.42648013294747883
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00854701	0.42648013294747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00854701	0.42648013294747883
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.00854701	0.42648013294747883
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00854701	0.42648013294747883
LEIGH SYNDROME; LS	0.00854701	0.42648013294747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00854701	0.42648013294747883
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00854701	0.42648013294747883
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.00854701	0.42648013294747883
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.00854701	0.42648013294747883
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00854701	0.42648013294747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.00854701	0.42648013294747883
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00854701	0.42648013294747883
LIVER FAILURE, INFANTILE, TRANSIENT	0.00854701	0.42648013294747883
#300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM;;SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00490196	0.2445988190610779
AXIAL OSTEOMALACIA	0.00490196	0.2445988190610779
GLYCOGEN STORAGE DISEASE II	0.00490196	0.2445988190610779
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00490196	0.2445988190610779
#613205 MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED;;MDCL	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00490196	0.2445988190610779
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.00490196	0.2445988190610779
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00490196	0.2445988190610779
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00490196	0.2445988190610779
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.00490196	0.2445988190610779
MCLEOD SYNDROME; MCLDS	0.00490196	0.2445988190610779
#614321 MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT	0.00490196	0.2445988190610779
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00490196	0.2445988190610779
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.00490196	0.2445988190610779
MUSCLE CRAMPS, FAMILIAL	0.00490196	0.2445988190610779
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00490196	0.2445988190610779
#300696 MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMAEMERY-DREIFUSS MUSCULAR DYSTROPHY 6, X-LINKED, INCLUDED; EDMD6, INCLUDED	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00490196	0.2445988190610779
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00490196	0.2445988190610779
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00490196	0.2445988190610779
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00490196	0.2445988190610779
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00490196	0.2445988190610779
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00490196	0.2445988190610779
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.00490196	0.2445988190610779
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00490196	0.2445988190610779
BETHLEM MYOPATHY 2; BTHLM2	0.00490196	0.2445988190610779
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00490196	0.2445988190610779
Congenital disorder of glycosylation, type IIh	0.00490196	0.2445988190610779
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00490196	0.2445988190610779
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00490196	0.2445988190610779
RIPPLING MUSCLE DISEASE; RMD	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.00490196	0.2445988190610779
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00490196	0.2445988190610779
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00490196	0.2445988190610779
#613158 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2N; LGMD2N;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMT2-RELATED	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.00490196	0.2445988190610779
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00490196	0.2445988190610779
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00490196	0.2445988190610779
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00490196	0.2445988190610779
MYOTILINOPATHY	0.00490196	0.2445988190610779
MYOPATHY, DISTAL, INFANTILE-ONSET	0.00490196	0.2445988190610779
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00490196	0.2445988190610779
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.00490196	0.2445988190610779
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.00490196	0.2445988190610779
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.00490196	0.2445988190610779
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.00490196	0.2445988190610779
STORMORKEN SYNDROME; STRMK	0.00490196	0.2445988190610779
GLYCOGEN STORAGE DISEASE V; GSD5	0.00490196	0.2445988190610779
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00490196	0.2445988190610779
#613723 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00490196	0.2445988190610779
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00490196	0.2445988190610779
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00490196	0.2445988190610779
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00490196	0.2445988190610779
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.00490196	0.2445988190610779
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00490196	0.2445988190610779
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00490196	0.2445988190610779
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.00490196	0.2445988190610779
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00490196	0.2445988190610779
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00490196	0.2445988190610779
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00490196	0.2445988190610779
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.00490196	0.2445988190610779
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00490196	0.2445988190610779
MYOTONIA, POTASSIUM-AGGRAVATED	0.00490196	0.2445988190610779
MUSCLE GLYCOGENOSIS, X-LINKED	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00490196	0.2445988190610779
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.00490196	0.2445988190610779
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00490196	0.2445988190610779
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00490196	0.2445988190610779
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00490196	0.2445988190610779
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.00490196	0.2445988190610779
#612998 EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4;;EMERY-DREIFUSS MUSCULAR DYSTROPHY 4 WITH VARIABLE FEATURES	0.00490196	0.2445988190610779
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00490196	0.2445988190610779
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.00490196	0.2445988190610779
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00490196	0.2445988190610779
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.00490196	0.2445988190610779
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00490196	0.2445988190610779
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.00490196	0.2445988190610779
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00490196	0.2445988190610779
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00490196	0.2445988190610779
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00490196	0.2445988190610779
MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	0.00490196	0.2445988190610779
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.00490196	0.2445988190610779
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.00490196	0.2445988190610779
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.00490196	0.2445988190610779
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00490196	0.2445988190610779
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00490196	0.2445988190610779
BETHLEM MYOPATHY 1	0.00490196	0.2445988190610779
COWCHOCK SYNDROME; COWCK	0.00490196	0.2445988190610779
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00490196	0.2445988190610779
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00490196	0.2445988190610779
CRAMPS, FAMILIAL ADOLESCENT	0.00490196	0.2445988190610779
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00490196	0.2445988190610779
#612999 EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5	0.00490196	0.2445988190610779
SALIH MYOPATHY; SALMY	0.00490196	0.2445988190610779
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00490196	0.2445988190610779
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.00490196	0.2445988190610779
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00490196	0.2445988190610779
#245340 ERYTHROCYTE LACTATE TRANSPORTER DEFECT;;LACTATE TRANSPORTER DEFECT, MYOPATHY DUE TO	0.00490196	0.2445988190610779
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00490196	0.2445988190610779
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.00490196	0.2445988190610779
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00490196	0.2445988190610779
NONAKA MYOPATHY	0.00490196	0.2445988190610779
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00490196	0.2445988190610779
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00490196	0.2445988190610779
MARINESCO-SJOGREN SYNDROME; MSS	0.00490196	0.2445988190610779
#613869 MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED;;MFM, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	0.00490196	0.2445988190610779
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.00490196	0.2445988190610779
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00490196	0.2445988190610779
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00490196	0.2445988190610779
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00490196	0.2445988190610779
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.00490196	0.2445988190610779
#300717 MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00490196	0.2445988190610779
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00490196	0.2445988190610779
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00490196	0.2445988190610779
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00490196	0.2445988190610779
DYSTROPHIA MYOTONICA 2	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00490196	0.2445988190610779
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.00490196	0.2445988190610779
GLYCOGEN STORAGE DISEASE XIII; GSD13	0.00490196	0.2445988190610779
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00490196	0.2445988190610779
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00490196	0.2445988190610779
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00490196	0.2445988190610779
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00490196	0.2445988190610779
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.00490196	0.2445988190610779
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00490196	0.2445988190610779
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00490196	0.2445988190610779
#604286 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E	0.00490196	0.2445988190610779
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.00490196	0.2445988190610779
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00490196	0.2445988190610779
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.00490196	0.2445988190610779
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.00490196	0.2445988190610779
#608810 MYOPATHY, MYOFIBRILLAR, 2, MFM2;;MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED;;MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE;;ALPHA-B CRYSTALLINOPATHY	0.00490196	0.2445988190610779
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00490196	0.2445988190610779
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00490196	0.2445988190610779
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00490196	0.2445988190610779
#609452 MYOPATHY, MYOFIBRILLAR, 4; MFM4;;MYOPATHY, MYOFIBRILLAR, ZASP-RELATED	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00490196	0.2445988190610779
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00490196	0.2445988190610779
LISSENCEPHALY 8; LIS8	0.00490196	0.2445988190610779
EPISODIC ATAXIA, TYPE 1; EA1	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00490196	0.2445988190610779
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00490196	0.2445988190610779
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00408163	0.20366585566676745
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.20366585566676745
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.20366585566676745
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.20366585566676745
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.20366585566676745
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00408163	0.20366585566676745
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.20366585566676745
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.20366585566676745
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.20366585566676745
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.20366585566676745
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00408163	0.20366585566676745
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00408163	0.20366585566676745
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.20366585566676745
FLOOD FACTOR DEFICIENCY	0.00408163	0.20366585566676745
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00408163	0.20366585566676745
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.20366585566676745
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00408163	0.20366585566676745
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.20366585566676745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.20366585566676745
ZINC, ELEVATED PLASMA	0.00408163	0.20366585566676745
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.20366585566676745
PENDRED SYNDROME	0.00408163	0.20366585566676745
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.00408163	0.20366585566676745
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.20366585566676745
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.20366585566676745
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00408163	0.20366585566676745
ALAND ISLAND EYE DISEASE	0.00408163	0.20366585566676745
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.20366585566676745
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00408163	0.20366585566676745
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00408163	0.20366585566676745
LIPASE DEFICIENCY, COMBINED	0.00408163	0.20366585566676745
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.20366585566676745
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00408163	0.20366585566676745
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.20366585566676745
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.20366585566676745
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.00408163	0.20366585566676745
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.20366585566676745
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00408163	0.20366585566676745
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.20366585566676745
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.20366585566676745
OVARIAN CANCER	0.00408163	0.20366585566676745
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.20366585566676745
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.20366585566676745
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.20366585566676745
DERMATITIS, ATOPIC	0.00408163	0.20366585566676745
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.20366585566676745
HEINZ BODY ANEMIAS	0.00408163	0.20366585566676745
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.20366585566676745
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.20366585566676745
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00408163	0.20366585566676745
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.20366585566676745
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.20366585566676745
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.20366585566676745
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00408163	0.20366585566676745
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.20366585566676745
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.20366585566676745
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.20366585566676745
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00408163	0.20366585566676745
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00408163	0.20366585566676745
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.00408163	0.20366585566676745
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.20366585566676745
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.20366585566676745
CALVARIAL HYPEROSTOSIS	0.00408163	0.20366585566676745
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00408163	0.20366585566676745
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.20366585566676745
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00408163	0.20366585566676745
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.00408163	0.20366585566676745
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.20366585566676745
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.20366585566676745
CARBOXYLESTERASE 1	0.00408163	0.20366585566676745
NEPHROSIALIDOSIS	0.00408163	0.20366585566676745
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.20366585566676745
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00408163	0.20366585566676745
FINGERPRINT BODY MYOPATHY	0.00408163	0.20366585566676745
CEPHALIN LIPIDOSIS	0.00408163	0.20366585566676745
GRANULOMAS, CONGENITAL CEREBRAL	0.00408163	0.20366585566676745
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.00408163	0.20366585566676745
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.20366585566676745
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.20366585566676745
PREMATURE OVARIAN FAILURE 1	0.00408163	0.20366585566676745
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.20366585566676745
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.20366585566676745
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.20366585566676745
OSTEOGENIC SARCOMA	0.00408163	0.20366585566676745
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.20366585566676745
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.20366585566676745
LARSEN-LIKE SYNDROME	0.00408163	0.20366585566676745
GAPO SYNDROME; GAPOS	0.00408163	0.20366585566676745
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.00408163	0.20366585566676745
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.20366585566676745
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.20366585566676745
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.20366585566676745
GONADOBLASTOMA	0.00408163	0.20366585566676745
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.00408163	0.20366585566676745
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.20366585566676745
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.20366585566676745
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.20366585566676745
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.20366585566676745
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.20366585566676745
ETHANOLAMINOSIS	0.00408163	0.20366585566676745
CHROMOSOME 10Q26 DELETION SYNDROME	0.00408163	0.20366585566676745
PARAOXONASE 1	0.00408163	0.20366585566676745
PYGMY	0.00408163	0.20366585566676745
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.20366585566676745
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00408163	0.20366585566676745
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00408163	0.20366585566676745
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00408163	0.20366585566676745
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00408163	0.20366585566676745
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.20366585566676745
MACROCYTOSIS, FAMILIAL	0.00408163	0.20366585566676745
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.20366585566676745
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.20366585566676745
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.20366585566676745
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.20366585566676745
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00408163	0.20366585566676745
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.20366585566676745
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00408163	0.20366585566676745
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00408163	0.20366585566676745
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.20366585566676745
BEETURIA	0.00408163	0.20366585566676745
ICHTHYOSIS, X-LINKED	0.00408163	0.20366585566676745
HOOFT DISEASE	0.00408163	0.20366585566676745
CITRULLINE TRANSPORT DEFECT	0.00408163	0.20366585566676745
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00408163	0.20366585566676745
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.20366585566676745
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00408163	0.20366585566676745
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.20366585566676745
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00408163	0.20366585566676745
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.20366585566676745
T-SUBSTANCE ANOMALY	0.00408163	0.20366585566676745
TRISOMY 18-LIKE SYNDROME	0.00408163	0.20366585566676745
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.20366585566676745
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.20366585566676745
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.20366585566676745
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00408163	0.20366585566676745
EMANUEL SYNDROME	0.00408163	0.20366585566676745
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.20366585566676745
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.00408163	0.20366585566676745
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.20366585566676745
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.20366585566676745
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00408163	0.20366585566676745
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.20366585566676745
SCHIZOPHRENIA 4	0.00408163	0.20366585566676745
DERMATOLEUKODYSTROPHY	0.00408163	0.20366585566676745
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.20366585566676745
DELETED IN AZOOSPERMIA	0.00408163	0.20366585566676745
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.20366585566676745
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.20366585566676745
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.20366585566676745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.20366585566676745
EHLERS-DANLOS SYNDROME, TYPE VI	0.00408163	0.20366585566676745
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.20366585566676745
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.20366585566676745
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00408163	0.20366585566676745
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.20366585566676745
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.00408163	0.20366585566676745
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.20366585566676745
BLOOD GROUP, DUFFY SYSTEM; FY	0.00408163	0.20366585566676745
ASPARTYLGLUCOSAMINURIA; AGU	0.00408163	0.20366585566676745
SPINAL ARACHNOIDITIS	0.00408163	0.20366585566676745
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.20366585566676745
GLUTATHIONURIA	0.00408163	0.20366585566676745
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.20366585566676745
PERRY SYNDROME	0.00408163	0.20366585566676745
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00408163	0.20366585566676745
LARON SYNDROME	0.00408163	0.20366585566676745
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.20366585566676745
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00408163	0.20366585566676745
MYELOPEROXIDASE DEFICIENCY	0.00408163	0.20366585566676745
REVESZ SYNDROME	0.00408163	0.20366585566676745
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.20366585566676745
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.20366585566676745
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.20366585566676745
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.20366585566676745
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00408163	0.20366585566676745
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.20366585566676745
PACMAN DYSPLASIA	0.00408163	0.20366585566676745
XYLOSIDASE DEFICIENCY	0.00408163	0.20366585566676745
COUMARIN RESISTANCE	0.00408163	0.20366585566676745
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.20366585566676745
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00408163	0.20366585566676745
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.20366585566676745
XANTHINURIA, TYPE I	0.00408163	0.20366585566676745
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.20366585566676745
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.20366585566676745
#170100 PROLIDASE DEFICIENCY	0.00408163	0.20366585566676745
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.20366585566676745
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.20366585566676745
XM SYSTEM	0.00408163	0.20366585566676745
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00408163	0.20366585566676745
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.00408163	0.20366585566676745
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.20366585566676745
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00408163	0.20366585566676745
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.20366585566676745
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.20366585566676745
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00408163	0.20366585566676745
ICHTHYOSIS AND MALE HYPOGONADISM	0.00408163	0.20366585566676745
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.20366585566676745
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.20366585566676745
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.20366585566676745
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00408163	0.20366585566676745
HYPERLEUCINE-ISOLEUCINEMIA	0.00408163	0.20366585566676745
EPILEPSY-TELANGIECTASIA	0.00408163	0.20366585566676745
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.20366585566676745
GLUTATHIONE REDUCTASE	0.00408163	0.20366585566676745
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.20366585566676745
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.20366585566676745
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.20366585566676745
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.20366585566676745
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00408163	0.20366585566676745
ONCOCYTOMA	0.00408163	0.20366585566676745
HYPOASCORBEMIA	0.00408163	0.20366585566676745
PITUITARY DWARFISM IV	0.00408163	0.20366585566676745
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.20366585566676745
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.20366585566676745
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00408163	0.20366585566676745
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.20366585566676745
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.20366585566676745
SALLA DISEASE	0.00408163	0.20366585566676745
LYMPHOKINE DEFICIENCY	0.00408163	0.20366585566676745
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.20366585566676745
APOLIPOPROTEIN(A)	0.00408163	0.20366585566676745
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.20366585566676745
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.20366585566676745
ACETYLATION, SLOW	0.00408163	0.20366585566676745
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.20366585566676745
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.20366585566676745
PROGESTERONE RESISTANCE	0.00408163	0.20366585566676745
HYPERPROGLUCAGONEMIA	0.00408163	0.20366585566676745
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.20366585566676745
AREDYLD	0.00408163	0.20366585566676745
